Susan Sather

2.6k total citations
34 papers, 1.8k citations indexed

About

Susan Sather is a scholar working on Immunology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Susan Sather has authored 34 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 10 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Susan Sather's work include Phagocytosis and Immune Regulation (20 papers), Macrophage Migration Inhibitory Factor (5 papers) and Cancer Mechanisms and Therapy (4 papers). Susan Sather is often cited by papers focused on Phagocytosis and Immune Regulation (20 papers), Macrophage Migration Inhibitory Factor (5 papers) and Cancer Mechanisms and Therapy (4 papers). Susan Sather collaborates with scholars based in United States, Germany and France. Susan Sather's co-authors include Douglas K. Graham, Nina Agabian, Gary L. Johnson, Deborah DeRyckere, Xiayuan Liang, Peter M. Henson, Jonathan L. Blank, Pär Gerwins, Brian Varnum and Jerry B. Lefkowitz and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Susan Sather

32 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan Sather United States 21 1.1k 771 305 222 183 34 1.8k
Jane Guo United States 19 798 0.7× 768 1.0× 122 0.4× 320 1.4× 62 0.3× 32 1.9k
Navin Rao United States 24 1.1k 1.1× 1.3k 1.7× 149 0.5× 558 2.5× 234 1.3× 43 2.9k
Eric G. Bremer United States 16 394 0.4× 814 1.1× 227 0.7× 172 0.8× 91 0.5× 19 1.5k
Harjit Dadi Canada 19 1.6k 1.5× 868 1.1× 228 0.7× 828 3.7× 63 0.3× 44 2.7k
Masayuki Noguchi Japan 21 393 0.4× 858 1.1× 308 1.0× 226 1.0× 120 0.7× 39 1.6k
Andris Avots Germany 21 913 0.9× 1.0k 1.3× 147 0.5× 285 1.3× 55 0.3× 36 1.8k
Esteban S. Masuda United States 33 1.2k 1.1× 1.2k 1.6× 65 0.2× 384 1.7× 235 1.3× 78 2.6k
Axel Choidas Germany 16 586 0.5× 1.4k 1.8× 147 0.5× 170 0.8× 75 0.4× 30 2.0k
Futoshi Suizu Japan 20 617 0.6× 1.4k 1.8× 287 0.9× 511 2.3× 108 0.6× 44 2.0k

Countries citing papers authored by Susan Sather

Since Specialization
Citations

This map shows the geographic impact of Susan Sather's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Sather with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Sather more than expected).

Fields of papers citing papers by Susan Sather

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Sather. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Sather. The network helps show where Susan Sather may publish in the future.

Co-authorship network of co-authors of Susan Sather

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Sather. A scholar is included among the top collaborators of Susan Sather based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Sather. Susan Sather is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
DeRyckere, Deborah, Amanda A. Hill, Xiaodong Wang, et al.. (2014). Abstract 1740: Development of a novel small molecule MER tyrosine kinase inhibitor with therapeutic activity in cell culture and mouse models of acute lymphoblastic leukemia. Cancer Research. 74(19_Supplement). 1740–1740. 2 indexed citations
2.
Zhang, Weihe, Deborah DeRyckere, Debra M. Hunter, et al.. (2014). UNC2025, a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor. Journal of Medicinal Chemistry. 57(16). 7031–7041. 118 indexed citations
3.
Liu, Jing, Weihe Zhang, Michael A. Stashko, et al.. (2013). UNC1062, a new and potent Mer inhibitor. European Journal of Medicinal Chemistry. 65. 83–93. 55 indexed citations
4.
Christoph, Sandra, Susan Sather, Jennifer Schlegel, et al.. (2013). Inhibition of MerTK increases chemosensitivity and decreases oncogenic potential in T-cell acute lymphoblastic leukemia. Blood Cancer Journal. 3(1). e101–e101. 41 indexed citations
5.
Lee‐Sherick, Alisa B., Susan Sather, Paul M. Armistead, et al.. (2013). Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia. Oncogene. 32(46). 5359–5368. 80 indexed citations
6.
Zhang, Weihe, Dehui� Zhang, Michael A. Stashko, et al.. (2013). Pseudo-Cyclization through Intramolecular Hydrogen Bond Enables Discovery of Pyridine Substituted Pyrimidines as New Mer Kinase Inhibitors. Journal of Medicinal Chemistry. 56(23). 9683–9692. 55 indexed citations
7.
Zhang, Weihe, Andrew L. McIver, Michael A. Stashko, et al.. (2013). Discovery of Mer Specific Tyrosine Kinase Inhibitors for the Treatment and Prevention of Thrombosis. Journal of Medicinal Chemistry. 56(23). 9693–9700. 40 indexed citations
8.
Christoph, Sandra, Alisa B. Lee‐Sherick, Susan Sather, Deborah DeRyckere, & Douglas K. Graham. (2013). Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia. Journal of Visualized Experiments. e50720–e50720. 4 indexed citations
9.
Linger, Rachel M.A., Richard A. Cohen, Christopher T. Cummings, et al.. (2012). Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer. Oncogene. 32(29). 3420–3431. 170 indexed citations
10.
Liu, Jing, Chao Yang, Catherine Simpson, et al.. (2012). Discovery of Small Molecule Mer Kinase Inhibitors for the Treatment of Pediatric Acute Lymphoblastic Leukemia. ACS Medicinal Chemistry Letters. 3(2). 129–134. 66 indexed citations
11.
Rogers, Aaron, et al.. (2011). Mer receptor tyrosine kinase inhibition impedes glioblastoma multiforme migration and alters cellular morphology. Oncogene. 31(38). 4171–4181. 52 indexed citations
12.
Christoph, Sandra, Deborah DeRyckere, Susan Sather, et al.. (2011). UNC569 As Novel Small Molecule Mer Receptor Tyrosine Kinase Inhibitor for Treatment of ALL. Blood. 118(21). 2589–2589. 3 indexed citations
13.
Keating, Amy K., Dana Salzberg, Susan Sather, et al.. (2006). Lymphoblastic leukemia/lymphoma in mice overexpressing the Mer (MerTK) receptor tyrosine kinase. Oncogene. 25(45). 6092–6100. 76 indexed citations
14.
Hermann, Monica, Anders Åsberg, Léon Reubsaet, et al.. (2002). Intake of grapefruit juice alters the metabolic pattern of cyclosporin A in renal transplant recipients. International Journal of Clinical Pharmacology and Therapeutics. 40(10). 451–456. 30 indexed citations
15.
Widmann, Christian, Susan Sather, Ryan Oyer, Gary L. Johnson, & Stephen C. Dreskin. (2001). In vitro activity of MEKK2 and MEKK3 in detergents is a function of a valine to serine difference in the catalytic domain. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1547(1). 167–173. 3 indexed citations
16.
Blank, Jonathan L., et al.. (1996). Molecular Cloning of Mitogen-activated Protein/ERK Kinase Kinases (MEKK) 2 and 3. Journal of Biological Chemistry. 271(10). 5361–5368. 201 indexed citations
17.
Tordo, Noël, Hervé Bourhy, Susan Sather, & Roger Ollo. (1993). Structure and Expression in Baculovirus of the Mokola Virus Glycoprotein: An Efficient Recombinant Vaccine. Virology. 194(1). 59–69. 35 indexed citations
18.
Jacob, Yves, Susan Sather, J. R. Martin, & Roger Ollo. (1991). Analysis of Krüppel control elements reveals that localized expression results from the interaction of multiple subelements.. Proceedings of the National Academy of Sciences. 88(13). 5912–5916. 17 indexed citations
19.
Sather, Susan & Nina Agabian. (1985). A 5' spliced leader is added in trans to both alpha- and beta-tubulin transcripts in Trypanosoma brucei.. Proceedings of the National Academy of Sciences. 82(17). 5695–5699. 76 indexed citations
20.
Milhausen, Michael, Richard G. Nelson, Susan Sather, Murray E. Selkirk, & Nina Agabian. (1984). Identification of a small rna containing the trypanosome spliced leader: A donor of shared 5′ sequences of trypanosomatid mRNAs?. Cell. 38(3). 721–729. 155 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jane Guo Breakdown of academic impact, for papers by Navin Rao Breakdown of academic impact, for papers by Eric G. Bremer Breakdown of academic impact, for papers by Harjit Dadi Breakdown of academic impact, for papers by Masayuki Noguchi Breakdown of academic impact, for papers by Andris Avots Breakdown of academic impact, for papers by Esteban S. Masuda Breakdown of academic impact, for papers by Axel Choidas Breakdown of academic impact, for papers by Futoshi Suizu
Rankless by CCL
2026